No chips you haven't missed it. They are about to start pase 2a trials of the HSV2 vax developed by Ian frazer and co. It is funded and read outs should start 6 months from now, roughly. Also you haven't missed those first read outs, final results, partner announcement, hpv trial phase 1, etc. I think if it partners there was estimates of up to 300 mill in up fronts for a 6 billion dollar market. Fingers crossed buddy!
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-52
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |